Latest filing published 24 Aug 2018 for IMV Inc. (formerly Immunovaccine Inc.), €896.
No signal scores available.
All filings by Alfred Smithers on record concern IMV Inc. (formerly Immunovaccine Inc.). In total, 16 filings cover trades dated from 2 May 2018 to 13 August 2018.
Purchases make up the whole of the open-market record (8 purchases, €228k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 option exercises.
The median purchase comes to €16k.
Most recently, on 24 August 2018, the filings show a transaction worth €896 in IMV Inc. (formerly Immunovaccine Inc.). The clock since the last published purchase (27 July 2018) now reads 3,015 days. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations